Chronic Rhinosinusitis (crs) Clinical Trials
2 recruiting trials for Chronic Rhinosinusitis (crs). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Chronic Rhinosinusitis (crs) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Cedars-Sinai Medical Center (1), Laboratoire de la Mer (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Lavender Aromatherapy (other, 1 trial), followed by Placebo Aromatherapy, Respimer® Hygiene-Prevention -Baby, kids, adults.
Track Chronic Rhinosinusitis (crs) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The...
Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms
The purpose of this post-market clinical investigation is to assess in a real-life setting, the effectiveness, usage, tolerance, safety and satisfaction of 4 isotonic and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Chronic Rhinosinusitis (crs), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Chronic Rhinosinusitis (crs), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Chronic Rhinosinusitis (crs), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.